Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Testosterone (TRT) vs Zinc: Zinc has the stronger overall evidence (8.5 vs 5.6/10); they're alternatives for bone health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Zinc wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Prescription-only and clinician-directed — this is a controlled substance, NOT a self-administered supplement, and we do not provide a non-medical dosing protocol. For context only: TRT for diagnosed hypogonadism is titrated to a mid-normal testosterone level. Intramuscular testosterone esters (cypionate/enanthate) are commonly dosed around 50–100 mg weekly (or ~100–200 mg every 2 weeks); long-acting testosterone undecanoate is dosed less frequently. Transdermal gels (~50–100 mg/day applied) and subcutaneous injection are alternative routes. Supraphysiologic anabolic-steroid doses are far higher and dangerous — not a regimen this library endorses.
Any time of day
Clinician-prescribed testosterone (intramuscular ester or transdermal gel) for diagnosed hypogonadism — controlled substance, prescription-only
15-25mg daily (a typical label dose, not the dose used in the cited trials, which used about 30 mg a day)
With meals
Zinc picolinate or zinc citrate
and 1 more not shown
and 4 more not shown
Weeks to months
Months
Months
Throughout use
2-4 weeks
2-4 weeks
4-8 weeks
Immediate
Effects of Testosterone Treatment in Older Men.
The New England journal of medicine (2016) · Rct · n=790
The coordinated Testosterone Trials: 790 men aged 65 or older with testosterone below 275 ng/dl and symptoms, testosterone gel or placebo gel for one year, each man in one or more of the Sexual Function, Physical Function and Vitality Trials.
Cardiovascular Safety of Testosterone-Replacement Therapy.
The New England journal of medicine (2023) · Rct · n=5246
TRAVERSE: a randomized, double-blind, placebo-controlled noninferiority trial of daily 1.62% testosterone gel in 5,246 men aged 45 to 80 with hypogonadism and existing or high risk of cardiovascular disease, mean follow-up 33 months.
Safety and Efficacy of Testosterone Therapy on Musculoskeletal Health and Clinical Outcomes in Men: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Endocrine practice (2023) · Meta analysis · n=1728
Systematic review and meta-analysis of 16 randomized placebo-controlled trials (1,728 men, mean age 77) of testosterone therapy on bone, muscle, fat and strength.
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta analysis · n=739
Zinc supplementation significantly reduced pain severity compared to placebo (Hedges's g = -1.541; 95% CI: -2.268 to -0.814; p < 0.001), representing a clinically meaningful reduction in pain.
Effects of Daily Zinc Alone or in Combination with Other Nutrient Supplements on the Risk of Malaria Parasitaemia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Nutrients (2023) · Meta analysis · n=1339
The effect sizes, represented as risk ratios (RRs) with 95% confidence intervals (CIs), were standardised by transforming them into log RRs and then pooling them using a fixed-effects or random-effects model depending on the heterogeneity across studies.
Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Nutrients (2022) · Meta analysis · n=806
Pooled analyses by the IBD subgroup showed a total population of 1677 with CD, for an overall mean zinc deficiency prevalence of 54% and 95% confidence intervals (CI) ranging from 0.51 to 0.56, versus 41% (95%CI 0.38-0.45) in the UC population (n = 806).
Zinc has a higher evidence score (8.5/10 vs 5.6/10) and wins in 2 of 3 categories.
For bone health, Zinc has a higher relevance score (70 vs 52).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
AREDS2 works for diagnosed AMD; lutein/screen-strain claims are weaker. Who actually benefits.
The popular one (saw palmetto) mostly fails in rigorous trials; beta-sitosterol is the better bet.
Selenium helps; iodine can WORSEN Hashimoto’s. The honest take on "thyroid support".
CoQ10, zinc, selenium, carnitine modestly help sperm parameters — but live-birth evidence is weak.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.